Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema
Clinical trial NCT02985242 · TERMINATED
Trial details
- NCT number
- NCT02985242
- Sponsor
- Hannover Medical School
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2018-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.